Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    Theseus Pharmaceuticals I...

    NASDAQ: THRX · Real-Time Price · USD
    4.07
    0.01 (0.25%)
    At close: Feb 13, 2024, 8:59 PM

    Theseus Pharmaceuticals Statistics

    Share Statistics

    Theseus Pharmaceuticals has 44.65M shares outstanding. The number of shares has increased by 0% in one year.

    Shares Outstanding

    n/a
    		 44.65M

    Shares Change (YoY)

    n/a
    		 0%

    Shares Change (QoQ)

    n/a
    		 0%

    Owned by Institutions (%)

    n/a
    		 n/a

    Shares Floating

    n/a
    		 n/a

    Failed to Deliver (FTD) Shares

    n/a
    		 1,504,081

    FTD / Avg. Volume

    n/a
    		 177.03%

    Short Selling Information

    The latest short interest is 401.68K, so 0.9% of the outstanding shares have been sold short.

    Short Interest

    n/a
    		 401.68K

    Short % of Shares Out

    n/a
    		 0.9%

    Short % of Float

    n/a
    		 1.9%

    Short Ratio (days to cover)

    n/a
    		 1.08

    Valuation Ratios

    The PE ratio is -4.07 and the forward PE ratio is null. Theseus Pharmaceuticals's PEG ratio is 0.07.

    PE Ratio

    n/a
    		 -4.07

    Forward PE

    n/a
    		 n/a

    PS Ratio

    n/a
    		 0

    Forward PS

    n/a
    		 n/a

    PB Ratio

    n/a
    		 0.92

    P/FCF Ratio

    n/a
    		 -5.74

    PEG Ratio

    n/a
    		 0.07
    Financial Ratio History

    Enterprise Valuation

    Theseus Pharmaceuticals has an Enterprise Value (EV) of 101.05M.

    EV / Sales

    n/a
    		 0

    EV / EBITDA

    n/a
    		 -1.87

    EV / EBIT

    n/a
    		 -3.07

    EV / FCF

    n/a
    		 -3.03

    Financial Position

    The company has a current ratio of 17.79, with a Debt / Equity ratio of 0.02.

    Current Ratio

    n/a
    		 17.79

    Quick Ratio

    n/a
    		 17.79

    Debt / Equity

    n/a
    		 0.02

    Debt / EBITDA

    n/a
    		 -0.07

    Debt / FCF

    n/a
    		 -0.12

    Interest Coverage

    n/a
    		 15.33

    Financial Efficiency

    Return on Equity is -22.68% and Return on Invested Capital is -23.78%.

    Return on Equity

    n/a
    		 -22.68%

    Return on Assets

    n/a
    		 -21.16%

    Return on Invested Capital

    n/a
    		 -23.78%

    Revenue Per Employee

    n/a
    		 n/a

    Profits Per Employee

    n/a
    		 $-1,238,947.37

    Employee Count

    n/a
    		 38

    Asset Turnover

    n/a
    		 0

    Inventory Turnover

    n/a
    		 n/a

    Taxes

    Income Tax

    n/a
    		 -3.53M

    Effective Tax Rate

    n/a
    		 6.97%

    Stock Price Statistics

    The stock price has increased by 0.25% in the last 52 weeks. The beta is 3.98, so Theseus Pharmaceuticals's price volatility has been higher than the market average.

    Beta

    n/a
    		 3.98

    52-Week Price Change

    n/a
    		 0.25%

    50-Day Moving Average

    n/a
    		 3.99

    200-Day Moving Average

    n/a
    		 4.75

    Relative Strength Index (RSI)

    n/a
    		 59.85

    Average Volume (20 Days)

    n/a
    		 849,600

    Income Statement

    Revenue

    n/a
    		 n/a

    Gross Profit

    n/a
    		 -438K

    Operating Income

    n/a
    		 -54.09M

    Net Income

    n/a
    		 -47.08M

    EBITDA

    n/a
    		 -54.09M

    EBIT

    n/a
    		 -54.14M

    Earnings Per Share (EPS)

    n/a
    		 -1.22
    Full Income Statement

    Balance Sheet

    The company has 94.61M in cash and 3.98M in debt, giving a net cash position of 90.63M.

    Cash & Cash Equivalents

    n/a
    		 94.61M

    Total Debt

    n/a
    		 3.98M

    Net Cash

    n/a
    		 90.63M

    Retained Earnings

    n/a
    		 -112.19M

    Total Assets

    n/a
    		 234.63M

    Working Capital

    n/a
    		 202.58M
    Full Balance Sheet

    Cash Flow

    In the last 12 months, operating cash flow was -32.95M and capital expenditures -455K, giving a free cash flow of -33.4M.

    Operating Cash Flow

    n/a
    		 -32.95M

    Capital Expenditures

    n/a
    		 -455K

    Free Cash Flow

    n/a
    		 -33.4M

    FCF Per Share

    n/a
    		 -0.87
    Full Cash Flow Statement

    Margins

    Gross Margin

    n/a
    		 n/a

    Operating Margin

    n/a
    		 n/a

    Pretax Margin

    n/a
    		 n/a

    Profit Margin

    n/a
    		 n/a

    EBITDA Margin

    n/a
    		 n/a

    EBIT Margin

    n/a
    		 n/a

    FCF Margin

    n/a
    		 n/a

    Dividends & Yields

    THRX does not appear to pay any dividends at this time.

    Dividend Per Share

    n/a
    		 n/a

    Dividend Yield

    n/a
    		 n/a

    Dividend Growth (YoY)

    n/a
    		 n/a

    Payout Ratio

    n/a
    		 n/a

    Earnings Yield

    n/a
    		 -24.56%

    FCF Yield

    n/a
    		 -17.42%
    Dividend Details

    Analyst Forecast

    Currently there are no analyst rating for THRX.

    Price Target

    n/a
    		 n/a

    Price Target Difference

    n/a
    		 n/a

    Analyst Consensus

    n/a
    		 n/a

    Analyst Count

    n/a
    		 n/a
    Stock Forecasts

    Fair Value

    There are several formulas that can be used to estimate the intrinsic value of a stock.

    Lynch Fair Value

    n/a
    		 n/a

    Lynch Upside

    n/a
    		 n/a

    Graham Number

    n/a
    		 n/a

    Graham Upside

    n/a
    		 n/a

    Scores

    Altman Z-Score

    n/a
    		 9.98

    Piotroski F-Score

    n/a
    		 3

    Add to Watchlist